Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions

  1. Caitlin N Spaulding
  2. Henry Louis Schreiber
  3. Weili Zheng
  4. Karen W Dodson
  5. Jennie E Hazen
  6. Matt S Conover
  7. Fengbin Wang
  8. Pontus Svenmarker
  9. Areli Luna-Rico
  10. Olivera Francetic
  11. Magnus Andersson
  12. Scott Hultgren  Is a corresponding author
  13. Edward H Egelman
  1. Washington University School of Medicine, United States
  2. University of Virginia, United States
  3. Umeå University, Sweden
  4. Institut Pasteur, France

Abstract

Uropathogenic E. coli (UPEC), which cause urinary tract infections (UTI), utilize type 1 pili, a chaperone usher pathway (CUP) pilus, to cause UTI and colonize the gut. The pilus rod, comprised of repeating FimA subunits, provides a structural scaffold for displaying the tip adhesin, FimH. We solved the 4.2 Å resolution structure of the type 1 pilus rod using cryo-electron microscopy. Residues forming the interactive surfaces that determine the mechanical properties of the rod were maintained by selection based on a global alignment of fimA sequences. We identified mutations that did not alter pilus production in vitro but reduced the force required to unwind the rod. UPEC expressing these mutant pili were significantly attenuated in bladder infection and intestinal colonization in mice. This study elucidates an unappreciated functional role for the molecular spring-like property of type 1 pilus rods in host-pathogen interactions and carries important implications for other pilus-mediated diseases.

Data availability

The following previously published data sets were used

Article and author information

Author details

  1. Caitlin N Spaulding

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
  2. Henry Louis Schreiber

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4501-9886
  3. Weili Zheng

    Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, United States
    Competing interests
    No competing interests declared.
  4. Karen W Dodson

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
  5. Jennie E Hazen

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
  6. Matt S Conover

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
  7. Fengbin Wang

    Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, United States
    Competing interests
    No competing interests declared.
  8. Pontus Svenmarker

    Department of Physics, Umeå University, Umeå, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1308-4923
  9. Areli Luna-Rico

    Biochemistry of Macromolecular Interactions Unit, Department of Structural Biology and Chemistry, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7538-5441
  10. Olivera Francetic

    Biochemistry of Macromolecular Interactions Unit, Department of Structural Biology and Chemistry, Institut Pasteur, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4145-5314
  11. Magnus Andersson

    Department of Physics, Umeå University, Umeå, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9835-3263
  12. Scott Hultgren

    Center for Women's Infectious Disease Research, Washington University School of Medicine, St Louis, United States
    For correspondence
    hultgren@wustl.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8785-564X
  13. Edward H Egelman

    Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, United States
    Competing interests
    Edward H Egelman, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4844-5212

Funding

National Institutes of Health (GM122510)

  • Edward H Egelman

Washington University School of Medicine (Monsanto Excellence Fund Graduate Fellowship)

  • Henry Louis Schreiber

National Institutes of Health (AI048689)

  • Scott Hultgren

National Institutes of Health (DK064540)

  • Scott Hultgren

National Institutes of Health (1F31DK107057)

  • Caitlin N Spaulding

National Institutes of Health (DK101171-02)

  • Matt S Conover

Svenska Forskningsrådet Formas (621-2013-5379)

  • Magnus Andersson

Agence Nationale de la Recherche (ANR-14-CE09-0004)

  • Olivera Francetic

Paris Pasteur University (Graduate Research Fellowship)

  • Areli Luna-Rico

Washington University School of Medicine (Lucille P. Markey Pathway for Pathobiology)

  • Henry Louis Schreiber

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The Washington University Animal Studies Committee approved all procedures used for the mouse experiments described in the present study (Protocol Application Number 20150226). Overall care of the animals was consistent with The Guide for the Care and Use of Laboratory Animals from the National Research Council and the USDA Animal Care Resource Guide. Every effort was made to minimize suffering.

Copyright

© 2018, Spaulding et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,868
    views
  • 510
    downloads
  • 73
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Caitlin N Spaulding
  2. Henry Louis Schreiber
  3. Weili Zheng
  4. Karen W Dodson
  5. Jennie E Hazen
  6. Matt S Conover
  7. Fengbin Wang
  8. Pontus Svenmarker
  9. Areli Luna-Rico
  10. Olivera Francetic
  11. Magnus Andersson
  12. Scott Hultgren
  13. Edward H Egelman
(2018)
Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions
eLife 7:e31662.
https://doi.org/10.7554/eLife.31662

Share this article

https://doi.org/10.7554/eLife.31662

Further reading

    1. Structural Biology and Molecular Biophysics
    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.